Clinical Trials at ENDO 08

The Annual Meeting Steering Committee invites all endocrine investigators to submit Clinical Trials abstracts to ENDO 08.

Given the complexities of review and approval by all investigators in a clinical trial, the ENDO chairs understand that limited data may be available at the abstract submission deadline - 11:59 PM CST, January 15th, 2008. All interested lead investigators who anticipate having data for presentation by June 1, 2008 should summit an abstract that details the trial design and rationale, inclusion criteria, primary clinical endpoints and any preliminary data. Any additional supporting data should be submitted by February 10, 2008 to this email address: Annual Meeting Steering Committee. The ENDO 08 Chairs will meet in February to review all submissions. At that time authors of promising Clinical Trials abstracts may be contacted for additional information.

At the time of initial abstract submission, all Clinical Trials authors may indicate that they choose to withdraw their abstract if it is not selected for an oral presentation at ENDO 08. In addition, authors may choose to embargo their abstract until the time of the ENDO meeting in San Francisco. Depending on the number and quality of submissions, Clinical Trials abstracts may be invited for presentation in several venues:

• Clinical Trials Symposium (longer format oral presentation)
• Clinical Trials Oral presentation
• Oral presentation in the appropriate scientific category (e.g. thyroid disorders - clinical)
• Poster presentation in the appropriate scientific category

For additional details on the ENDO 08 abstract submission process, please visit: http://www.endo-society.org/endo/abstracts/

If you have questions concerning the Clinical Trials process for ENDO 08, please contact: Robert Bartel, Associate Director, Education at rbartel@endo-society.org